Connect with us

Government

Best Penny Stocks To Buy Now? 4 Monkeypox Stocks To Watch This Week

Monkeypox penny stocks to watch this week.
The post Best Penny Stocks To Buy Now? 4 Monkeypox Stocks To Watch This Week appeared first on Penny Stocks…

Published

on

Monkeypox stocks are beginning to capture broad market attention, and, yes, penny stocks are among the most speculated upon. But there are a few things you have to understand when approaching this niche. Like COVID stocks, more assumptions are being made about “what might happen” than are actually confirmed.

We saw this occur with several of the hottest monkeypox stocks this quarter. Namely, Siga Technologies Inc. (NASDAQ: SIGA) and several other companies developing potential treatments. While many have enjoyed significant moves higher, most are trading far off their highs.

Why are some monkeypox stocks down right now?

It has to do with comments from the FDA. In Siga’s case, the Administration came out and said that Siga’s Tpoxx had no human data demonstrating the efficacy of the treatment for monkeypox. In addition, the FDA also explained that it already has an FDA-approved vaccine for preventing monkeypox disease and an FDA-cleared diagnostic test.

So why are other monkeypox stocks trending in the stock market today? Much like the coronavirus pandemic, where only a few vaccines gained mass adoption, it was diagnostic companies and ones developing preventative platforms that continued capturing attention. Think back to disinfecting companies, mask businesses, and testing & diagnostic companies. These tended to trend a bit longer after the market decided there were viable drugs and drugmakers to watch. Is this the case today?

Monkeypox Stocks To Watch

Headlines spanning the globe have highlighted the spread of the virus. Today French Health Minister Francois Braun said 2,271 people were now infected with monkeypox in France. This comes after California declared a State of Emergency over the outbreak earlier this week. They are the latest state to join the growing roster following this course of action. Illinois and New York have also declared states of emergency.

“Monkeypox is a rare disease caused by infection with the monkeypox virus…[it] is part of the same family of viruses as variola virus, the virus that causes smallpox. Monkeypox symptoms are similar to smallpox symptoms, but milder, and monkeypox is rarely fatal….[it] is not related to chickenpox,” the CDC notes on its website.

Some preventative suggestions offered by the CDC include home disinfection, testing, and personal protective equipment, among other things. In light of this, and that nearly every state in the United States has recorded cases, monkeypox stocks remain a focus. This time, it might be more of a “picks and shovels” as opposed to a vaccine treatment development point of interest.

Best Penny Stocks To Buy

Thanks to the breakout of stocks like HKD, AMTD, and others, small-cap stocks and penny stocks, in general, have gained a very bright spotlight. The “monkeypox prevention stocks” came about today thanks to a big move in Applied DNA (NASDAQ: APDN).

Shares of APDN stock exploded after the company announced that it began analytical validation of a PCR-based monkeypox virus test. If it gets validated, the company has plans to submit a package to the New York State Department of Health for approval. As of its postmarket highs of $5.68 on Tuesday, APDN stock made a move of 787% from its premarket lows of just $0.64.

[Read More] 4 Penny Stocks To Watch After HKD Stock Explodes Over 2000%

If this sympathy sentiment is something that has piqued your interest, it’s essential to understand that speculation is playing a significant role right now. Given this as the case, there’s no shortage of volatility and potential for big moves in either direction, as we’ve seen with the likes of SIGA stock and others.

  1. Chembio Diagnostics Inc. (NASDAQ: CEMI)
  2. Aethlon Medical (NASDAQ: AEMD)
  3. E-Home Household Service Holdings Ltd. (NASDAQ: EJH)
  4. Tonix Pharmaceuticals (NASDAQ: TNXP)

Chembio Diagnostics Inc. (NASDAQ: CEMI)

Shares of Chembio (CEMI Stock Report)caught a massive surge in trading activity in the stock market today. CEMI stock traded its highest single-day volume in 2022 on August 2nd. The company offers point-of-care diagnostic services focused on infectious diseases. With a speculative focus, it had several keywords that helped trigger the attention of those looking for companies in this niche of monkeypox stocks.

Given the list of panels that Chembio currently offers, CEMI stock may be gaining some speculative momentum as a result. The company has stated that its DPP technology also offers broad market applications beyond infectious disease. Though, there is not a direct link to monkeypox itself. With upcoming earnings this week, it will be interesting to see if Chembio comments on how it may (or may not) be addressing the uptick in monkeypox cases and if it will work toward developing a viable solution.

Aethlon Medical (NASDAQ: AEMD)

Aethlon’s (AEMD Stock Report) pipeline of treatments targets organ-threatening diseases. Its Hemopurifier has been studied to fight future COVID-19 variants that can impact the efficacy of certain vaccines. It was given Breakthrough Device status in treating patients with metastatic cancer, and an Investigational Device Exemption was granted in 2019 for cancer. It was also updated to include a clinical study of patients with viral infections, including COVID.

Unlike Chembio, there has been mention of monkeypox directly. Aethlon says that “pre-clinical Hemopurifier studies have validated the broad-spectrum capture of numerous viral threats. These include Chikungunya, Dengue and West Nile virus, as well as Vaccinia and Monkeypox, which serve as models for human Smallpox infection.”

Given this link, AEMD stock could be on the list of penny stocks to watch as monkeypox cases increase.

E-Home Household Service Holdings Ltd. (NASDAQ: EJH)

Shares of E-Home Household (EJH Stock Report) have traded higher since it released news on July 27th linking it to monkeypox. The company offers household services in China. Everything from housekeeping and nannying to elderly and hospital care fall in its basket of services. However, late last month, E-Home announced monkeypox-related news, placing it on the radar for some traders.

[Read More] Best Penny Stocks To Buy Now? 4 To Watch As APDN Stock Jumps 230%+

E-Home reported that it would explore potential monkeypox treatment programs. Its subsidiary, Zhongrun (Fujian) Pharmaceutical Co., Ltd., specializes in personal care products specific to Chinese medicine. Wenshan Xie, Chairman and CEO of E-Home, expanded on the update saying, “Traditional Chinese medicines have been relied upon for thousands of years and have the capacity to treat a large variety of illnesses. I believe we have an important opportunity to leverage Zhongrun’s strength in the area of traditional Chinese medicine to uncover potential treatment options for the monkeypox virus.”

Though vague and still “exploratory” in nature, that July headline puts EJH on the list of monkeypox stocks to watch.

Tonix Pharmaceuticals (NASDAQ: TNXP)

While some monkeypox treatment stocks have fallen out of favor, others remain in focus. Tonix Pharmaceuticals (TNXP Stock Report) is one of these companies, and shares surged during postmarket trading on August 2nd.

The company’s infectious disease pipeline includes developing a vaccine to prevent smallpox and monkeypox called TNX-801. TNXP stock is on the radar as more cases pop up globally. Tonix also announced a new collaboration with the Kenya Medical Research Institute for developing TNX-801 as a vaccine for the prevention of monkeypox and smallpox infection. A Phase 1 clinical study could begin during the first half of 2023, said Tonix in a July PR. Regardless of the longer-term timing, TNXP stock has been one of the monkeypox stocks on the watch list over the last few weeks.

If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!!

The post Best Penny Stocks To Buy Now? 4 Monkeypox Stocks To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Read More

Continue Reading

Government

Low Iron Levels In Blood Could Trigger Long COVID: Study

Low Iron Levels In Blood Could Trigger Long COVID: Study

Authored by Amie Dahnke via The Epoch Times (emphasis ours),

People with inadequate…

Published

on

Low Iron Levels In Blood Could Trigger Long COVID: Study

Authored by Amie Dahnke via The Epoch Times (emphasis ours),

People with inadequate iron levels in their blood due to a COVID-19 infection could be at greater risk of long COVID.

(Shutterstock)

A new study indicates that problems with iron levels in the bloodstream likely trigger chronic inflammation and other conditions associated with the post-COVID phenomenon. The findings, published on March 1 in Nature Immunology, could offer new ways to treat or prevent the condition.

Long COVID Patients Have Low Iron Levels

Researchers at the University of Cambridge pinpointed low iron as a potential link to long-COVID symptoms thanks to a study they initiated shortly after the start of the pandemic. They recruited people who tested positive for the virus to provide blood samples for analysis over a year, which allowed the researchers to look for post-infection changes in the blood. The researchers looked at 214 samples and found that 45 percent of patients reported symptoms of long COVID that lasted between three and 10 months.

In analyzing the blood samples, the research team noticed that people experiencing long COVID had low iron levels, contributing to anemia and low red blood cell production, just two weeks after they were diagnosed with COVID-19. This was true for patients regardless of age, sex, or the initial severity of their infection.

According to one of the study co-authors, the removal of iron from the bloodstream is a natural process and defense mechanism of the body.

But it can jeopardize a person’s recovery.

When the body has an infection, it responds by removing iron from the bloodstream. This protects us from potentially lethal bacteria that capture the iron in the bloodstream and grow rapidly. It’s an evolutionary response that redistributes iron in the body, and the blood plasma becomes an iron desert,” University of Oxford professor Hal Drakesmith said in a press release. “However, if this goes on for a long time, there is less iron for red blood cells, so oxygen is transported less efficiently affecting metabolism and energy production, and for white blood cells, which need iron to work properly. The protective mechanism ends up becoming a problem.”

The research team believes that consistently low iron levels could explain why individuals with long COVID continue to experience fatigue and difficulty exercising. As such, the researchers suggested iron supplementation to help regulate and prevent the often debilitating symptoms associated with long COVID.

It isn’t necessarily the case that individuals don’t have enough iron in their body, it’s just that it’s trapped in the wrong place,” Aimee Hanson, a postdoctoral researcher at the University of Cambridge who worked on the study, said in the press release. “What we need is a way to remobilize the iron and pull it back into the bloodstream, where it becomes more useful to the red blood cells.”

The research team pointed out that iron supplementation isn’t always straightforward. Achieving the right level of iron varies from person to person. Too much iron can cause stomach issues, ranging from constipation, nausea, and abdominal pain to gastritis and gastric lesions.

1 in 5 Still Affected by Long COVID

COVID-19 has affected nearly 40 percent of Americans, with one in five of those still suffering from symptoms of long COVID, according to the U.S. Centers for Disease Control and Prevention (CDC). Long COVID is marked by health issues that continue at least four weeks after an individual was initially diagnosed with COVID-19. Symptoms can last for days, weeks, months, or years and may include fatigue, cough or chest pain, headache, brain fog, depression or anxiety, digestive issues, and joint or muscle pain.

Tyler Durden Sat, 03/09/2024 - 12:50

Read More

Continue Reading

Government

Walmart joins Costco in sharing key pricing news

The massive retailers have both shared information that some retailers keep very close to the vest.

Published

on

As we head toward a presidential election, the presumed candidates for both parties will look for issues that rally undecided voters. 

The economy will be a key issue, with Democrats pointing to job creation and lowering prices while Republicans will cite the layoffs at Big Tech companies, high housing prices, and of course, sticky inflation.

The covid pandemic created a perfect storm for inflation and higher prices. It became harder to get many items because people getting sick slowed down, or even stopped, production at some factories.

Related: Popular mall retailer shuts down abruptly after bankruptcy filing

It was also a period where demand increased while shipping, trucking and delivery systems were all strained or thrown out of whack. The combination led to product shortages and higher prices.

You might have gone to the grocery store and not been able to buy your favorite paper towel brand or find toilet paper at all. That happened partly because of the supply chain and partly due to increased demand, but at the end of the day, it led to higher prices, which some consumers blamed on President Joe Biden's administration.

Biden, of course, was blamed for the price increases, but as inflation has dropped and grocery prices have fallen, few companies have been up front about it. That's probably not a political choice in most cases. Instead, some companies have chosen to lower prices more slowly than they raised them.

However, two major retailers, Walmart (WMT) and Costco, have been very honest about inflation. Walmart Chief Executive Doug McMillon's most recent comments validate what Biden's administration has been saying about the state of the economy. And they contrast with the economic picture being painted by Republicans who support their presumptive nominee, Donald Trump.

Walmart has seen inflation drop in many key areas.

Image source: Joe Raedle/Getty Images

Walmart sees lower prices

McMillon does not talk about lower prices to make a political statement. He's communicating with customers and potential customers through the analysts who cover the company's quarterly-earnings calls.

During Walmart's fiscal-fourth-quarter-earnings call, McMillon was clear that prices are going down.

"I'm excited about the omnichannel net promoter score trends the team is driving. Across countries, we continue to see a customer that's resilient but looking for value. As always, we're working hard to deliver that for them, including through our rollbacks on food pricing in Walmart U.S. Those were up significantly in Q4 versus last year, following a big increase in Q3," he said.

He was specific about where the chain has seen prices go down.

"Our general merchandise prices are lower than a year ago and even two years ago in some categories, which means our customers are finding value in areas like apparel and hard lines," he said. "In food, prices are lower than a year ago in places like eggs, apples, and deli snacks, but higher in other places like asparagus and blackberries."

McMillon said that in other areas prices were still up but have been falling.

"Dry grocery and consumables categories like paper goods and cleaning supplies are up mid-single digits versus last year and high teens versus two years ago. Private-brand penetration is up in many of the countries where we operate, including the United States," he said.

Costco sees almost no inflation impact

McMillon avoided the word inflation in his comments. Costco  (COST)  Chief Financial Officer Richard Galanti, who steps down on March 15, has been very transparent on the topic.

The CFO commented on inflation during his company's fiscal-first-quarter-earnings call.

"Most recently, in the last fourth-quarter discussion, we had estimated that year-over-year inflation was in the 1% to 2% range. Our estimate for the quarter just ended, that inflation was in the 0% to 1% range," he said.

Galanti made clear that inflation (and even deflation) varied by category.

"A bigger deflation in some big and bulky items like furniture sets due to lower freight costs year over year, as well as on things like domestics, bulky lower-priced items, again, where the freight cost is significant. Some deflationary items were as much as 20% to 30% and, again, mostly freight-related," he added.

Read More

Continue Reading

Government

Walmart has really good news for shoppers (and Joe Biden)

The giant retailer joins Costco in making a statement that has political overtones, even if that’s not the intent.

Published

on

As we head toward a presidential election, the presumed candidates for both parties will look for issues that rally undecided voters. 

The economy will be a key issue, with Democrats pointing to job creation and lowering prices while Republicans will cite the layoffs at Big Tech companies, high housing prices, and of course, sticky inflation.

The covid pandemic created a perfect storm for inflation and higher prices. It became harder to get many items because people getting sick slowed down, or even stopped, production at some factories.

Related: Popular mall retailer shuts down abruptly after bankruptcy filing

It was also a period where demand increased while shipping, trucking and delivery systems were all strained or thrown out of whack. The combination led to product shortages and higher prices.

You might have gone to the grocery store and not been able to buy your favorite paper towel brand or find toilet paper at all. That happened partly because of the supply chain and partly due to increased demand, but at the end of the day, it led to higher prices, which some consumers blamed on President Joe Biden's administration.

Biden, of course, was blamed for the price increases, but as inflation has dropped and grocery prices have fallen, few companies have been up front about it. That's probably not a political choice in most cases. Instead, some companies have chosen to lower prices more slowly than they raised them.

However, two major retailers, Walmart (WMT) and Costco, have been very honest about inflation. Walmart Chief Executive Doug McMillon's most recent comments validate what Biden's administration has been saying about the state of the economy. And they contrast with the economic picture being painted by Republicans who support their presumptive nominee, Donald Trump.

Walmart has seen inflation drop in many key areas.

Image source: Joe Raedle/Getty Images

Walmart sees lower prices

McMillon does not talk about lower prices to make a political statement. He's communicating with customers and potential customers through the analysts who cover the company's quarterly-earnings calls.

During Walmart's fiscal-fourth-quarter-earnings call, McMillon was clear that prices are going down.

"I'm excited about the omnichannel net promoter score trends the team is driving. Across countries, we continue to see a customer that's resilient but looking for value. As always, we're working hard to deliver that for them, including through our rollbacks on food pricing in Walmart U.S. Those were up significantly in Q4 versus last year, following a big increase in Q3," he said.

He was specific about where the chain has seen prices go down.

"Our general merchandise prices are lower than a year ago and even two years ago in some categories, which means our customers are finding value in areas like apparel and hard lines," he said. "In food, prices are lower than a year ago in places like eggs, apples, and deli snacks, but higher in other places like asparagus and blackberries."

McMillon said that in other areas prices were still up but have been falling.

"Dry grocery and consumables categories like paper goods and cleaning supplies are up mid-single digits versus last year and high teens versus two years ago. Private-brand penetration is up in many of the countries where we operate, including the United States," he said.

Costco sees almost no inflation impact

McMillon avoided the word inflation in his comments. Costco  (COST)  Chief Financial Officer Richard Galanti, who steps down on March 15, has been very transparent on the topic.

The CFO commented on inflation during his company's fiscal-first-quarter-earnings call.

"Most recently, in the last fourth-quarter discussion, we had estimated that year-over-year inflation was in the 1% to 2% range. Our estimate for the quarter just ended, that inflation was in the 0% to 1% range," he said.

Galanti made clear that inflation (and even deflation) varied by category.

"A bigger deflation in some big and bulky items like furniture sets due to lower freight costs year over year, as well as on things like domestics, bulky lower-priced items, again, where the freight cost is significant. Some deflationary items were as much as 20% to 30% and, again, mostly freight-related," he added.

Read More

Continue Reading

Trending